|
Re: New name.
|
7
|
Resverlogix Corp.
|
May 10, 2022 10:03PM
|
|
Re: US Covid #'s
|
4
|
Resverlogix Corp.
|
May 09, 2022 02:24PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
6
|
Resverlogix Corp.
|
May 09, 2022 01:10PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
10
|
Resverlogix Corp.
|
May 09, 2022 10:46AM
|
|
Re: A couple of things
|
2
|
Resverlogix Corp.
|
May 03, 2022 01:28PM
|
|
Re: A couple of things
|
1
|
Resverlogix Corp.
|
May 03, 2022 12:30PM
|
|
Re: A couple of things
|
5
|
Resverlogix Corp.
|
May 03, 2022 12:12PM
|
|
Re: A couple of things
|
9
|
Resverlogix Corp.
|
May 03, 2022 01:38AM
|
|
Re: Market Woes
|
6
|
Resverlogix Corp.
|
Apr 30, 2022 11:23AM
|
|
Re: BTD
|
6
|
Resverlogix Corp.
|
Apr 24, 2022 01:58PM
|
|
BTD
|
11
|
Resverlogix Corp.
|
Apr 23, 2022 01:47PM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
5
|
Zenith Epigenetics
|
Apr 21, 2022 11:57AM
|
|
Re: Debt
|
4
|
Zenith Epigenetics
|
Apr 03, 2022 12:26PM
|
|
Debt
|
7
|
Zenith Epigenetics
|
Apr 02, 2022 01:01PM
|
|
Re: RVX- Exempt Distribution
|
5
|
Resverlogix Corp.
|
Apr 01, 2022 11:42PM
|
|
CEO Pay
|
14
|
Resverlogix Corp.
|
Mar 31, 2022 02:33PM
|
|
Re: Covid China
|
5
|
Resverlogix Corp.
|
Mar 30, 2022 12:57AM
|
|
Re: Was checking out SEDAR...
|
5
|
Zenith Epigenetics
|
Mar 28, 2022 06:00PM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
11
|
Resverlogix Corp.
|
Mar 25, 2022 04:14PM
|
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
10
|
Resverlogix Corp.
|
Mar 18, 2022 09:50PM
|
